Gross
- "Furthermore, the coadministration of Shikonin, a potent PKM2 inhibitor, reverted the tumor development induced by the HMGCR signaling pathway.Species-specific monitoring activities represent fundamental tools for […]"View
Active 7 months, 1 week ago